350 rub
Journal №5 for 2013 г.
Article in number:
Suppositories development based on dry extract leaved arnica
Authors:
V.F. Okhotnikova, N.S. Miheeva, O.A. Semkina, M.A. Dzhavakhyan, A.F. Azarkova, T.V. Kachalina, T.A. Sokolskaya
Abstract:
With the purpose of a choice of optimum structure suppository the widely used bases were used: Supporin M, Firm fat of the mark A, Vitepsol W-35, Supacir NaS, PEG. On the basis of the carried out experimental data the conclusion is made that optimum suppository base on the basis «Firm fat» (Adepssolidus) .With the purpose of obtaining fine-dispersed and stable emulsions are used monohlycerides. As the solvent of medicinal substance is used 1,2 propylene glycol. As superficial - active substance strengthening intensity diffusion and absorption of substances in a straight rectum at the expense of increase of their solubility and influence on mucous by decrease of a superficial tension of a layer, the Twin-80 is included. The estimation of the quality of suppositories according to the GF XI.
Pages: 11-15
References

  1. Anarbaeva R.M., Toksanbaeva ZH.S. Biofarmacevticheskie i mikrobiologicheskie issledovanija suppozitoriev s gliderininom // Astana medic. zhurn. 2000. № 3. S. 118-120.
  2. Baginskaja A.I., Leskova T.E. Leonidova JU.A., Mineeva M.F., Kolkhir V.K., Sokolskaja T.A.Farmakologicheskie svojjstva sukhogo ehkstrakta travy Arniki oblistvennojj // Voprosy biologicheskojj, medicinskojj i farmacevticheskojj khimii. 2012. № 1.S. 189-194.
  3. Bykov V.A., Suslina S.N., Sjomkina O.A., Dzhavakhjan M.A. Farmacevticheskaja tekhnologija. EHkstemporalnoe izgotovlenie. Uchebno-metodicheskoe posobie. M. 2010. S. 520.
  4. Gosudarstvennyjj reestr lekarstvennykh sredstv. 2011.
  5. Gosudarstvennaja farmakopeja SSSR: XIizd. Vyp. 2. M.: Medicina. 1998.
  6. Dugashvili N.G. Sozdanie suppozitornykh osnov differencirovannogo rjada // Medicinskie novosti Gruzii. 1998. № 11-12. S. 5-7.
  7. Kovalenko L.I., Pavlikhina I.A., Popov D.M. Izuchenie vlijanija nekotorykh faktorov na polnotu izvlechenija flavonoidov v otvar zveroboja // Aktualnye voprosy farmacevticheskojj tekhnologii: nauch. trudy NIIF. M. 1994. T. XXXII. S. 163-168.
  8. Kondrateva T.S. Ivanova L.A. i dr. Tekhnologija lekarstvennykh form. V 2-kh tomakh / pod. red. T.S. Kondratevojj. M.: Medicina. 1991. T. 1.
  9. Koneev F.A., Severceva O.V., Makarov V.G. K voprosu fundamentalnykh problem tekhnologii lekarstv// Tezisy. dokl. Mezhdunar. nauch. konf. «Farmacija v XXI veke: innovacii i tradicii». SPb. 1999. S. 164-165.
  10. Korzhavykh EH.A.Nomenklatura lekarstvennykh form: spravochnoe posobie. M. 2004. 153s.
  11. Kravchenko N.V., Muravev I.A., Pshukov JU.G. Vybor optimalnykh razmerov chastic pri sovmestnom ehkstragirovanii razlichnykh vidov rastitelnogo syrja, vkhodjashhikh v sostav sborov // Farmacija. 1976. № 6. S. 9-13.
  12. Standarty kachestva lekarstvennykh sredstv. Osnovnye polozhenija. OST 91500.05.001-00. M. 2000. S. 54.
  13. SHikova JU.V.Razrabotka sostava, tekhnologii i biofarmacevticheskogo issledovanija lekarstvennykh form s dibunolom: Diss. kand. farm. nauk. Ufa. 1999. S. 163.
  14. Galensa R. Hochdruck fussaigkeits chromatographie von Flavonoiden. Hannover Copy-Teum/Druck. 1979. P. 98.
  15. Rice Evans C.A., Miller N.S., Bolwell P.G. The relative antioxidant activities plant - derived poliphenolic flavonoids // Free Radical. Res. 1995. Apr. №. 22(4). P. 353-375.